Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Deisseroth

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|January 17, 2004
Genetic systems for the diagnosis and treatment of human diseaseAlbert Deisseroth
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Normal and pathological functions of mammalian retroelementsAlbert Deisseroth
Blood|December 24, 2005
Tumor vascular targeting therapy with viral vectorsYanzheng Liu, Albert Deisseroth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Acute Myeloid Leukemia Response Measures Other Than Complete RemissionDonna Przepiorka, Albert Deisseroth, Ann T Farrell
Clinical Immunology (Orlando, Fla.)|May 1, 2007
Damage associated molecular pattern moleculesMichael T Lotze, Albert Deisseroth, Anna Rubartelli
Cancer Gene Therapy|April 30, 2003
Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colonHakan Akbulut, Lixin Zhang, Yucheng Tang, et al.
Human Gene Therapy|March 1, 2007
Methods for delivery of adenoviral vectors to tumor vasculatureYanzheng Liu, James Koziol, Albert Deisseroth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanomaPingchuan Li, Yanzheng Liu, Jonathan Maynard, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2009
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the agedYu Cheng Tang, Marilyn Thoman, Phyllis-Jean Linton, et al.
Human Gene Therapy|July 10, 2004
Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanomaYanzheng Liu, Tao Ye, Dejun Sun, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|January 17, 2004
Genetic systems for the diagnosis and treatment of human diseaseAlbert Deisseroth
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Normal and pathological functions of mammalian retroelementsAlbert Deisseroth
Blood|December 24, 2005
Tumor vascular targeting therapy with viral vectorsYanzheng Liu, Albert Deisseroth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Acute Myeloid Leukemia Response Measures Other Than Complete RemissionDonna Przepiorka, Albert Deisseroth, Ann T Farrell
Clinical Immunology (Orlando, Fla.)|May 1, 2007
Damage associated molecular pattern moleculesMichael T Lotze, Albert Deisseroth, Anna Rubartelli
Cancer Gene Therapy|April 30, 2003
Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colonHakan Akbulut, Lixin Zhang, Yucheng Tang, et al.
Human Gene Therapy|March 1, 2007
Methods for delivery of adenoviral vectors to tumor vasculatureYanzheng Liu, James Koziol, Albert Deisseroth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanomaPingchuan Li, Yanzheng Liu, Jonathan Maynard, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2009
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the agedYu Cheng Tang, Marilyn Thoman, Phyllis-Jean Linton, et al.
Human Gene Therapy|July 10, 2004
Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanomaYanzheng Liu, Tao Ye, Dejun Sun, et al.
Pageof 4